1[1]Kasielski M,Nowak D.Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease[J].Respir Med,2001,95(6):448.
2[2]Szkudlarek U,Zdziechowski A,Wit kowski K,et al.Effect of inhaled N-acetylcysteine on hydrogen peroxide exhalation in healthy subjects[J].Pulm Pharmacol Ther,2004,17(3):155.
3[3]Macnee W.Oxidants/antioxidants and chronic obstructive pulmonary disease:pathogenesis to therapy[J].Novartis Found Symp,2001,234:169.
4[4]Antonicelli F,Parmentier M,Drost EM,et al.N-acetylcysteine inhibits oxidant-mediated interleukin-8 expression and NF-KappaB nuclear binding in alveolar epithelial cells[J].Free Radic Biol Med,2002,32(6):492.
5[5]Cavarra E,Lucattelli M,Gambelli F,et al.Human SLPI inactivation after cigarette smoke exposure in a new in vivo model of pulmonary oxidative stress[J].Am J Physiol Lung Cell Mol Physiol,2001,281 (2):L412.
6[6]Metnitz PG,Bartens C,Fischer M,et al.Antioxidant status in patients with acute respiratory distress syndrome[J].Intensive Care Med,1999,25 (2):180.
7[7]Laurent T,Markert M,Feihl F,et al.Oxidant-antioxidant balance in granulocytes during ARDS.Effect of N-cetylcysteine[J].Chest,1996,109(1):163.
8[8]Domenighetti G,Quattropani C,Schaller MD,et al.Therapeutic use of N-acetylcysteine in acute lung diseases[J].Rev Mal Respir,1999,16(1):29.
